Publication Information

{'id': 'https://openalex.org/W2466451466', 'doi': 'https://doi.org/10.1634/theoncologist.2016-0055', 'title': 'Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents', 'display_name': 'Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents', 'publication_year': 2016, 'publication_date': '2016-07-08', 'ids': {'openalex': 'https://openalex.org/W2466451466', 'doi': 'https://doi.org/10.1634/theoncologist.2016-0055', 'mag': '2466451466', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/27401894', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/5061539'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2016-0055', 'pdf_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2016-0055', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'review', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2016-0055', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5047177507', 'display_name': 'Jeffrey S. Weber', 'orcid': 'https://orcid.org/0000-0002-4962-2957'}, 'institutions': [{'id': 'https://openalex.org/I4210086933', 'display_name': 'NYU Langone Health', 'ror': 'https://ror.org/005dvqh91', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210086933']}], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Jeffrey S. Weber', 'raw_affiliation_strings': ['aLaura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York, USA'], 'affiliations': [{'raw_affiliation_string': 'aLaura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York, USA', 'institution_ids': ['https://openalex.org/I4210086933']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011325668', 'display_name': 'Michael A. Postow', 'orcid': 'https://orcid.org/0000-0002-3367-7961'}, 'institutions': [{'id': 'https://openalex.org/I205783295', 'display_name': 'Cornell University', 'ror': 'https://ror.org/05bnh6r87', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I205783295']}, {'id': 'https://openalex.org/I39965400', 'display_name': 'Kettering University', 'ror': 'https://ror.org/03rcspa57', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I39965400']}, {'id': 'https://openalex.org/I1334819555', 'display_name': 'Memorial Sloan Kettering Cancer Center', 'ror': 'https://ror.org/02yrq0923', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1334819555']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael Postow', 'raw_affiliation_strings': ['bMemorial Sloan Kettering Cancer Center, New York, New York, USA', 'cWeill Cornell Medical College, New York, New York, USA'], 'affiliations': [{'raw_affiliation_string': 'cWeill Cornell Medical College, New York, New York, USA', 'institution_ids': ['https://openalex.org/I205783295']}, {'raw_affiliation_string': 'bMemorial Sloan Kettering Cancer Center, New York, New York, USA', 'institution_ids': ['https://openalex.org/I39965400', 'https://openalex.org/I1334819555']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108566653', 'display_name': 'Christopher D. Lao', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I27837315', 'display_name': 'University of Michigan–Ann Arbor', 'ror': 'https://ror.org/00jmfr291', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I27837315']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Christopher D. Lao', 'raw_affiliation_strings': ['dDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA'], 'affiliations': [{'raw_affiliation_string': 'dDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA', 'institution_ids': ['https://openalex.org/I27837315']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5034365278', 'display_name': 'Dirk Schadendorf', 'orcid': 'https://orcid.org/0000-0003-3524-7858'}, 'institutions': [{'id': 'https://openalex.org/I4210119759', 'display_name': 'Essen University Hospital', 'ror': 'https://ror.org/02na8dn90', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210119759']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'Dirk Schadendorf', 'raw_affiliation_strings': ['eUniversity Hospital Essen, Essen, Germany'], 'affiliations': [{'raw_affiliation_string': 'eUniversity Hospital Essen, Essen, Germany', 'institution_ids': ['https://openalex.org/I4210119759']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 6, 'corresponding_author_ids': ['https://openalex.org/A5047177507'], 'corresponding_institution_ids': ['https://openalex.org/I4210086933'], 'apc_list': {'value': 3494, 'currency': 'USD', 'value_usd': 3494, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 4.84, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 224, 'citation_normalized_percentile': {'value': 0.999397, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '21', 'issue': '10', 'first_page': '1230', 'last_page': '1240'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10158', 'display_name': 'Cancer Immunotherapy and Biomarkers', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11491', 'display_name': 'CAR-T cell therapy research', 'score': 0.998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11533', 'display_name': 'Melanoma and MAPK Pathways', 'score': 0.9963, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/immune-checkpoint', 'display_name': 'Immune checkpoint', 'score': 0.4465949}], 'concepts': [{'id': 'https://openalex.org/C2781433595', 'wikidata': 'https://www.wikidata.org/wiki/Q2459042', 'display_name': 'Ipilimumab', 'level': 4, 'score': 0.92171425}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.92027247}, {'id': 'https://openalex.org/C2780057760', 'wikidata': 'https://www.wikidata.org/wiki/Q13896859', 'display_name': 'Pembrolizumab', 'level': 4, 'score': 0.9081991}, {'id': 'https://openalex.org/C2780030458', 'wikidata': 'https://www.wikidata.org/wiki/Q7041828', 'display_name': 'Nivolumab', 'level': 4, 'score': 0.8695578}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.7732224}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.49011216}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.48189908}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.45711377}, {'id': 'https://openalex.org/C2780851360', 'wikidata': 'https://www.wikidata.org/wiki/Q21686041', 'display_name': 'Immune checkpoint', 'level': 4, 'score': 0.4465949}, {'id': 'https://openalex.org/C177713679', 'wikidata': 'https://www.wikidata.org/wiki/Q679690', 'display_name': 'Intensive care medicine', 'level': 1, 'score': 0.4453067}, {'id': 'https://openalex.org/C2777658100', 'wikidata': 'https://www.wikidata.org/wiki/Q180614', 'display_name': 'Melanoma', 'level': 2, 'score': 0.43672058}, {'id': 'https://openalex.org/C2777701055', 'wikidata': 'https://www.wikidata.org/wiki/Q1427096', 'display_name': 'Immunotherapy', 'level': 3, 'score': 0.3661598}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.35827196}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.33779058}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.08612135}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': True}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D061026', 'descriptor_name': 'Programmed Cell Death 1 Receptor', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061067', 'descriptor_name': 'Antibodies, Monoclonal, Humanized', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D060908', 'descriptor_name': 'CTLA-4 Antigen', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}, {'descriptor_ui': 'D060908', 'descriptor_name': 'CTLA-4 Antigen', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000074324', 'descriptor_name': 'Ipilimumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008545', 'descriptor_name': 'Melanoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077594', 'descriptor_name': 'Nivolumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D061026', 'descriptor_name': 'Programmed Cell Death 1 Receptor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 5, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2016-0055', 'pdf_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2016-0055', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc5061539', 'pdf_url': 'https://europepmc.org/articles/pmc5061539?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061539', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'http://hdl.handle.net/2027.42/140047', 'pdf_url': 'http://deepblue.lib.umich.edu/bitstream/2027.42/140047/1/onco1230.pdf', 'source': {'id': 'https://openalex.org/S4306400393', 'display_name': 'Deep Blue (University of Michigan)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I27837315', 'host_organization_name': 'University of Michigan–Ann Arbor', 'host_organization_lineage': ['https://openalex.org/I27837315'], 'host_organization_lineage_names': ['University of Michigan–Ann Arbor'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/27401894', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1634/theoncologist.2016-0055', 'pdf_url': 'https://theoncologist.onlinelibrary.wiley.com/doi/pdfdirect/10.1634/theoncologist.2016-0055', 'source': {'id': 'https://openalex.org/S15523509', 'display_name': 'The Oncologist', 'issn_l': '1083-7159', 'issn': ['1083-7159', '1549-490X'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310316295', 'host_organization_name': 'AlphaMed Press', 'host_organization_lineage': ['https://openalex.org/P4310316295'], 'host_organization_lineage_names': ['AlphaMed Press'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.86, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 16, 'referenced_works': ['https://openalex.org/W1990675339', 'https://openalex.org/W2097995306', 'https://openalex.org/W2112121482', 'https://openalex.org/W2128035403', 'https://openalex.org/W2128758225', 'https://openalex.org/W2139192665', 'https://openalex.org/W2148706732', 'https://openalex.org/W2152897456', 'https://openalex.org/W2156353875', 'https://openalex.org/W2160834915', 'https://openalex.org/W2166662937', 'https://openalex.org/W2177405394', 'https://openalex.org/W2313175236', 'https://openalex.org/W2337494164', 'https://openalex.org/W2560367415', 'https://openalex.org/W2572174216'], 'related_works': ['https://openalex.org/W4362545845', 'https://openalex.org/W4313890856', 'https://openalex.org/W4241093956', 'https://openalex.org/W4236421112', 'https://openalex.org/W3108601240', 'https://openalex.org/W3043703771', 'https://openalex.org/W2973740076', 'https://openalex.org/W2899127460', 'https://openalex.org/W2800160190', 'https://openalex.org/W2766929851'], 'abstract_inverted_index': {'Abstract': [0], 'Immune': [1], 'checkpoint': [2], 'inhibitors': [3], 'have': [4], 'emerged': [5], 'as': [6, 92], 'a': [7, 37, 105], 'mainstay': [8], 'of': [9, 22, 40, 54, 81, 107, 109, 156, 163, 177, 182, 204], 'melanoma': [10, 167], 'therapy': [11], 'and': [12, 65, 90, 122, 130, 146, 180, 201], 'are': [13], 'playing': [14], 'an': [15, 79], 'increasingly': [16], 'important': [17, 206], 'role': [18], 'in': [19, 59, 95, 166], 'the': [20, 50, 60, 115, 153, 178, 191, 199], 'treatment': [21], 'other': [23, 69], 'tumor': [24], 'types.': [25], 'The': [26], 'clinical': [27, 111, 127, 144], 'benefit': [28], 'afforded': [29], 'by': [30, 36, 104, 159], 'these': [31, 205], 'treatments': [32], 'can': [33], 'be': [34, 74], 'accompanied': [35], 'unique': [38], 'spectrum': [39], 'adverse': [41, 45], 'events,': [42], 'called': [43], 'immune-related': [44, 164], 'events': [46], '(irAEs),': [47], 'which': [48], 'reflect': [49], 'drug’s': [51], 'immune-based': [52], 'mechanism': [53], 'action.': [55], 'IrAEs': [56], 'typically': [57], 'originate': [58], 'skin,': [61], 'gastrointestinal': [62], 'tract,': [63], 'liver,': [64], 'endocrine': [66], 'system,': [67], 'although': [68], 'organ': [70], 'systems': [71], 'may': [72], 'also': [73], 'affected.': [75], 'This': [76], 'article': [77], 'provides': [78], 'overview': [80], 'irAEs': [82, 108, 137, 158, 183], 'associated': [83, 138, 193], 'with': [84, 97, 139, 170, 194], 'anti-programmed': [85], 'death-1': [86], '(anti-PD-1)': [87], 'antibodies': [88], '(nivolumab': [89], 'pembrolizumab)': [91], 'monotherapy': [93], 'or': [94, 172], 'combination': [96], 'anti-cytotoxic': [98], 'T-lymphocyte': [99], 'antigen-4': [100], 'inhibition': [101], '(ipilimumab),': [102], 'followed': [103], 'discussion': [106], 'special': [110], 'interest': [112], 'based': [113, 142], 'on': [114, 133, 143], 'potential': [116], 'for': [117], 'morbidity,': [118], 'frequent': [119], 'steroid': [120], 'use,': [121], 'inpatient': [123], 'admission.': [124], 'We': [125, 150], 'review': [126], 'trial': [128], 'data': [129], 'provide': [131], 'recommendations': [132], 'how': [134], 'to': [135, 197], 'manage': [136], 'anti-PD-1': [140, 195], 'agents': [141], 'experience': [145], 'established': [147], 'management': [148, 181], 'guidelines.': [149], 'further': [151], 'illustrate': [152], 'practical': [154], 'considerations': [155], 'managing': [157], 'presenting': [160], 'three': [161], 'cases': [162], 'toxicity': [165], 'patients': [168], 'treated': [169], 'nivolumab': [171], 'pembrolizumab.': [173], 'A': [174], 'better': [175], 'understanding': [176], 'identification': [179], 'will': [184], 'help': [185], 'inform': [186], 'health': [187], 'care': [188], 'providers': [189], 'about': [190], 'risks': [192], 'treatment,': [196], 'ensure': [198], 'safe': [200], 'appropriate': [202], 'use': [203], 'new': [207], 'treatments.': [208]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2466451466', 'counts_by_year': [{'year': 2024, 'cited_by_count': 14}, {'year': 2023, 'cited_by_count': 10}, {'year': 2022, 'cited_by_count': 24}, {'year': 2021, 'cited_by_count': 30}, {'year': 2020, 'cited_by_count': 26}, {'year': 2019, 'cited_by_count': 32}, {'year': 2018, 'cited_by_count': 53}, {'year': 2017, 'cited_by_count': 30}, {'year': 2016, 'cited_by_count': 4}], 'updated_date': '2024-12-08T07:01:31.574725', 'created_date': '2016-07-22'}